By using this site, you agree to the Privacy Policy and Terms of Use.

CANCER IDENTIFICATION
Healthcare Technology August 22, 2022

Evolution of Biopsies in Cancer Identification

Healthcare Technology August 18, 2022

The Growth of Digital Health –

Biomarkers
Healthcare Pharma Technology August 9, 2022

Biomarkers & Their Increasingly Crucial Role

Tower B5, Office 101, Magarpatta SEZ Hadapsar, Pune-411013, India

+91 20 48598285

[email protected]

MarketsandMarkets Conferences > Blog
4th Annual MarketsandMarkets Epigenetics Congress Healthcare News Pharma

Speaker Interview with Lorenzo Pasquali for 4th Annual MarketsandMarkets Epigenetics Congress

London, UK July 23, 2019 – MarketsandMarkets recently interviewed Lorenzo Pasquali, Group Leader, Endocrine Regulatory Genomics Laboratory IGTP, Spain regarding the 4th Annual MarketsandMarkets Epigenetics Congress, taking place on 3-4 October 2019 at Radisson Blu Edwardian, Grafton, London, UK. Dr. Lorenzo Pasquali is Group Leader of the Endocrine Regulatory Genomics laboratory at IGTP, Barcelona, Spain […]

Read More
MarketsandMarkets Epigenetics Congress Healthcare News Pharma Uncategorized

AveXis Directs to Catalent’s Paragon for Extra Gene Therapy Producing Capacity

Catalent has approved AveXis that, a Novartis Company to use its brand-new commercial manufacturing center near Baltimore-Washington International Airport as an extra site production site for its spinal muscular atrophy (SMA) gene therapy Zolgensma® (onasemnogene abeparvovec-xioi). A collaboration contract was signed by Catalent and AveXis to ensure long term strategic agreement but has not been […]

Read More
Next Gen Immuno Oncology Congress Healthcare News Pharma Uncategorized

Genmab Partners Raised $503M U.S. IPO on Cancer Antibodies with BliNK Biomedical

Genmab through collaboration with Blink biomedicals raised a whopping $503 Million through an American initial public offering (IPO) all this got revealed on Friday during an event. Genmab also launched an up to $200 million-per-product cancer therapy with Blink biomedicals. Blink biomedicals got a license approved by Genmab exclusively for antibodies targeting CD47, which Genmab […]

Read More
Autoimmune Disease Uncategorized

A Study Identifies Autoimmune Disease to be Linked with Testicular Cancer

Washington D.C. [USA]: According to the Scientists, an autoimmune disease looks to be linked with testicular cancer that affects men. Known to us as ‘testicular cancer-associated paraneoplastic encephalitis’, it is the reason behind any serious neurological symptoms found in men. They lose control of the limbs, speech and eye movements progressively. The autoimmune disease starts with a […]

Read More
4th Annual MarketsandMarkets Epigenetics Congress Uncategorized

Passage Bio on Producing Gene Therapies with Catalent’s Paragon

About five months ago Passage Bio that basically produces gene therapies for not so common monogenic CNS disease, in partnership with Catalent’s paragon launched a unit that is devoted to manufacturing suite Paragon Harman’s, MD, facility. The other cGMP suite whose worth is not being revealed yet is expected to hit it’s functional phase from […]

Read More
Industry 4.0:cybersecurity & iiot News Technology

Safety in Industry 4.0 – Are you prepared for the Automation?

With the rapid change of the modern world into an ‘Industry 4.0’ economy, it can be said that the change is somewhat similar to the Industrial revolution of the 18th century. Industries have undergone a significant change in terms of production and optimization of the whole process, things like machine learning; AI i.e. artificial intelligence […]

Read More
MarketsandMarkets Industry 4.0 Conference: Cybersecurity & IIoT News Technology

Bravatek Solutions Signs Partnership Agreement for IIOT Technology

AUSTIN, Texas, June 25, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Bravatek Solutions, Inc. (OTC Pink: BVTK) (“Bravatek” or the “Company”) declared that it entered into an arrangement with MC smart controls, Inc. to display and advertise its IIOT technology on an absolute basis to customers like policymakers and military. Along with this, BVTK will […]

Read More
MarketsandMarkets Microbiome - Advanced Therapeutics and Sequencing Congress Healthcare News Pharma

Microba Partners with Korean Company Macrogen to Develop Global Microbiome Service Offering

Australian biotech giant Microba has made an alliance with Macrogen to develop microbiome research services for the offshore market. An MOU has got signed at the Macrogen Headquarters in Seoul on 14 March 2019 defining all the partnership terms and condition. Through this MOU, Macrogen and Microba will establish a close cooperation system. With this […]

Read More
Next Gen Immuno Oncology Congress Healthcare Pharma

The Bispecific and Complex mAbs Driving Process Development Innovation, Roche

According to a statement by the VP of Roche technical development bioprocessing, Wolfgang Kuhne said that the older processes used to produce monoclonal antibodies like Herceptin and Avastin are not sufficient to produce complex and advanced pharmaceuticals. A bioprocess international European summit was held in Vienna, Austria during which delegates were told that making candidates […]

Read More